JY231 Injection Clinical Trials
6 recruitingDrug
Not Applicable6
Showing 1–6 of 6 trials
Recruiting
Not Applicable
JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies
B-cell Malignancies
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China36 enrolled1 locationNCT07065279
Recruiting
Not Applicable
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
B-ALLB-NHL
Tongji Hospital20 enrolled1 locationNCT06689917
Recruiting
Not Applicable
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
B Acute Lymphoblastic LeukemiaB-Non Hodgkin Lymphoma
Affiliated Hospital of Guangdong Medical University20 enrolled1 locationNCT06940960
Recruiting
Not Applicable
JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
Autoimmune Diseases of the Nervous System
Tongji Hospital20 enrolled1 locationNCT06797024
Recruiting
Not Applicable
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
B Acute Lymphoblastic LeukemiaB-Non Hodgkin Lymphoma
Shenzhen Genocury Biotech Co., Ltd.20 enrolled1 locationNCT06890065
Recruiting
Not Applicable
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
B-ALLB-NHL
Shenzhen Genocury Biotech Co., Ltd.20 enrolled1 locationNCT06678282